Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$262.75 - $319.31 $131,375 - $159,655
500 New
500 $156,000
Q2 2020

Jul 30, 2020

SELL
$197.81 - $242.74 $1.9 Million - $2.33 Million
-9,602 Closed
0 $0
Q1 2020

Apr 28, 2020

BUY
$182.24 - $241.7 $911 - $1,208
5 Added 0.05%
9,602 $1.95 Million
Q4 2019

Jan 16, 2020

BUY
$189.21 - $243.2 $1.12 Million - $1.44 Million
5,932 Added 161.86%
9,597 $2.31 Million
Q2 2019

Jul 19, 2019

BUY
$166.7 - $195.41 $7,001 - $8,207
42 Added 1.16%
3,665 $675,000
Q1 2019

Apr 25, 2019

SELL
$180.87 - $203.88 $1,989 - $2,242
-11 Reduced 0.3%
3,623 $688,000
Q4 2018

Feb 12, 2019

BUY
$178.4 - $208.25 $648,305 - $756,780
3,634 New
3,634 $707,000
Q3 2018

Nov 13, 2018

SELL
$185.29 - $208.89 $1.38 Million - $1.56 Million
-7,467 Closed
0 $0
Q2 2018

Aug 13, 2018

BUY
$166.05 - $186.51 $1.24 Million - $1.39 Million
7,467 New
7,467 $1.38 Million
Q1 2018

May 14, 2018

SELL
$169.43 - $198.0 $1.18 Million - $1.38 Million
-6,976 Closed
0 $0
Q4 2017

Feb 06, 2018

SELL
$168.79 - $188.59 $293,019 - $327,392
-1,736 Reduced 19.93%
6,976 $1.21 Million
Q3 2017

Nov 13, 2017

BUY
$167.29 - $191.0 $1.46 Million - $1.66 Million
8,712
8,712 $1.62 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $150B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Camelot Portfolios, LLC Portfolio

Follow Camelot Portfolios, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Camelot Portfolios, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Camelot Portfolios, LLC with notifications on news.